Summary
In a community-based study of second-generation Japanese-American men known to have a high prevalence of both Type 2 (non-insulin-dependent) diabetes and impaired glucose tolerance, there was a highly significant association of coronary heart disease with glucose intolerance in a study sample of 219 men. Intra-abdominal cross sectional fat area determined by computed tomography was significantly elevated in men with coronary heart disease even after adjustment for glucose intolerance and body mass index (p=0.026). Other differences that were significantly related to coronary heart disease after adjustment for glucose intolerance were lower high density lipoprotein cholesterol levels (p=0.001), elevated total triglyceride and very low density lipoprotein triglyceride (p<0.001), and elevated fasting insulin and C-peptide levels p=0.001. When these variables were tested in a stepwise multiple logistic regression model, significant independent associations with coronary heart disease were found only for total triglyceride and fasting C-peptide after adjustment for glucose tolerance status. Variables identified to be associated with coronary heart disease were interpreted as representing or manifesting an insulin resistant state. Thus, insulin resistance may be the underlying risk factor aetiologically linking glucose intolerance with coronary heart disease.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Chait A, Bierman EL, Brunzell JD (1985) Diabetic macroangiopathy. In: Alberti KGMM, Krall LP (eds) The diabetes annual, Vol 1. Elsevier, New York, pp 323–348
Ruderman NB, Haudenschild C (1984) Diabetes as an atherogenic factor. Prog Cardiovasc Dis 26:373–412
Pyorala K, Savolainen E, Kaukola S, Haapakoski J (1985) Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive value during 9 1/2-year follow-up of the Helsinki Policeman Study Population. Acta Med Scand 701 [Suppl]:38–52
Welborn TA, Wearne K (1979) Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations. Diab Care 2:154–160
Eschwege E, Richard JL, Thibault N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE (1985) Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris prospective study, ten years later. Horm Metab Res 15 [Suppl]: 41–46
Modan M, Halkin H, Almong S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z (1985) Hyperinsulinemia: a link between hypertension, obesity, and glucose intolerance. J Clin Invest 75: 809–817
Stout RW (1987) Insulin and atheroma-an update. Lancet I: 1077–1079
Garcia-Webb P, Bonser AM, Whiting D, Masarei JRL (1983) Insulin resistance — a risk factor for coronary heart disease? Scand J Clin Lab Invest 43:677–685
Alberti KGMM, Davis SN, Monti L, Moller N, Piatti P, Heine R (1987) Methods for assessing insulin sensitivity in man. Biochem Soc Trans 15:1027–1028
Garg A, Helderman JH, Koffler M, Ayuso R, Rosenstock J, Raskin P (1988) Relationship between lipoprotein levels and in vivo insulin action in normal young white men. Metabolism 37: 982–987
Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY (1990) Association of elevated fasting C-peptide level and increased intraabdominal fat distribution with development of NIDDM in Japanese-American men. Diabetes 39:104–111
Malmquist J, Birgerstam G (1986) Assays of pancreatic B cell secretory products: utility in investigative and clinical diabetology. Scand J Clin Lab Invest 46:705–713
Stern MP, Haffner SM (1986) Body fat distribution and hyperinsulinemia as risk factors for diabetes and cardiovascular disease. Arteriosclerosis 6:123–130
Kissebah AH, Peiris AN (1989) Biology of regional body fat distribution: relationship to non-insulin-dependent diabetes mellitus. Diab Metab Rev 5:83–109
Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR (1977) Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women. Ann Intern Med 87:393–397
Reckless JPD, Betteridge DJ, Wu P, Payne B, Galton DJ (1978) High density and low density lipoproteins and prevalence of vascular disease in diabetes mellitus. Br Med J 1:883–886
Howard BV (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28:613–628
Sicree RA, Zimmet PZ, King HOM, Coventry JS (1987) Plasma insulin response among Naurans: prediction of deterioration in glucose tolerance over 6 yr. Diabetes 36:179–186
Fontbonne A, Eschwege E, Cambien F, Richard J-L, Ducimetiere, Thibult N, Warnet J-M, Claude J-R, Rosselin G-E (1989) Hypertriglyceridaemia as a risk factor of coronary heart disease in mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris prospective study. Diabetologia 32:300–304
Robertson TL, Kato H, Rhoads GG, Kagan A, Marmot M, Syme SL, Gordon T, Worth RM, Belsky JL, Dock DS, Miyanishi M, Kawamoto S (1977) Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii, and California: incidence of myocardial infarction and death from coronary heart disease. Am J Cardiol 39:239–243
Fujimoto WY, Akanuma Y, Kanazawa Y, Mashiko S, Leonetti D, Wahl P (1989) Plasma insulin levels in Japanese and Japanese-American men with type 2 diabetes may be related to the occurrence of cardiovascular disease. Diab Res Clin Prac 6: 121–127
Fujimoto WY, Leonetti DL, Kinyoun JL, Newell-Morris L, Shuman WP, Stolov WC, Wahl PW (1987) Prevalence of diabetes mellitus and impaired glucose tolerance among second generation Japanese-American men. Diabetes 36:721–729
Fujimoto WY, Leonetti DL, Kinyoun JC, Shuman WP, Stolov WC, Wahl PW (1987) Prevalence of complications among second-generation Japanese-American men with diabetes, impaired glucose tolerance, and normal glucose tolerance. Diabetes 36:730–739
Poffenbarger RS, Wing AL, Hyde RT (1978) Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 108:161–175
Rose GA, Blackburn H (1968) Cardiovascular survey methods. World Health Organization, Geneva, pp 172–175
Rose GA, Blackburn H (1968) Cardiovascular survey methods. World Health Organization, Geneva, pp 137–141
Shuman WP, Newell-Morris LL, Leonetti DL, Wahl PW, Moceri VM, Moss AA, Fujimoto WY (1986) Abnormal body fat distribution detected by computed tomography in diabetic men. Invest Radiol 21:483–487
Warnick GR (1986) Enzymatic methods for quantification of lipoproteins. Meth Enzymol 129:101–123
Hughes L, Lahiri A, Raftery EB (1989) Coronary disease in Asians associated with high insulin and C-peptide concentration. Br Heart J 61:445
Larsson B, Bjorntorp P, Tibblin G (1981) The health consequences of moderate obesity. Int J Obes 5:97–116
Larsson B, Svardsudd K, Welin L, Wilhelmsen L, Bjorntorp P, Tibblin G (1984) Abdominal adipose tissue distribution, obesity and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J 288:1401–1404
Peiris AN, Sothmann MS, Hoffmann RG, Hennes MI, Wilson CR, Gustafson AB, Kissebah AH (1989) Adiposity, fat distribution, and cardiovascular risk. Ann Intern Med 110:867–872
Donahue RP, Abbott RD, Bloom E, Reed DM, Yano K (1987) Central obesity and coronary heart disease in men. Lancet I:821–824
Newell-Morris LL, Treder RP, Shuman WP, Fujimoto WY (1989) Fatness, fat distribution and glucose tolerance in secondgeneration Japanese-American (Nisei) men. Am J Clin Nutr 50: 9–18
Despres J-P, Moorjani S, Ferland M, Tremblay A, Lupien PJ, Nadeau A, Pinault S, Theriault G, Bouchard C (1989) Adipose tissue distribution and plasma lipoprotein levels in obese women. Importance of intra-abdominal fat. Arteriosclerosis 9: 203–210
Janka HU (1985) Five-year incidence of major macrovascular complications in diabetes mellitus. Horm Metab Res 15 [Suppl]: 15–19
Hulley SP, Rosenman RH, Bawol RD, Brand RJ (1980) Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 302: 1383–1389
Austin MA (1989) Plasma triglyceride as a risk factor for coronary heart disease. The epidemiologic evidence and beyond. Am J Epidemiol 129:249–259
Bottiger L-E, Carlson LA (1980) Risk factors for ischaemic vascular death for men in the Stockholm prospective study. Atherosclerosis 36:389–408
Cambien F, Jacqueson A, Richard JL, Warnet JM, Ducimetiere P, Claude JR (1986) Is the level of serum triglyceride a significant predictor of coronary death in “normocholesterolemic” subjects? The Paris prospective study. Am J Epidemiol 124:624–632
Gabor J, Spain M, Kalant N (1980) Composition of serum very-low-density and high-density lipoproteins in diabetes. Clin Chem 26:1261–1265
Schwandt P (1985) Very low density lipoproteins in type II diabetes mellitus and risk of atherosclerosis. Horm Metab Res 15 [Suppl]: 80–83
Mahley RW (1982) Atherogenic hyperlipoproteinemia: the cellular and molecular biology of plasma lipoproteins altered by dietary fat and cholesterol. Med Clin N Am 66:375–402
Uusitupa M. Siitonen O, Voutilainen E, Aro A, Hersio K, Pyorala K, Penttila I, Ehnholm C (1986) Serum lipids and lipoproteins in newly diagnosed non-insulin-dependent (type II) diabetic patients, with special reference to factors influencing HDL-cholesteroI and triglyceride levels. Diab Care 9:17–22
Castelli WP, Doyle JT, Gordon T, Hames CG, Hjortland MC, Hulley SB, Kagan A, Zukel WJ (1977) HDL cholesterol and other lipids in coronary heart disease. The cooperative lipoprotein phenotyping study. Circulation 55:767–772
Miller NE, Forde OH, Thelle DS, Mjos OD (1977) The Tromso heart study. High-density lipoprotein and coronary heart-disease: a prospective case control study. Lancet I: 965–967
Laakso M, Voutilainen E, Pyorala K, Sarlund H (1985) Association of low HDL and HDL2 cholesterol with coronary heart disease in noninsulin-dependent diabetics. Arteriosclerosis 5: 653–658
Welborn TA, Knuiman M, McCann V, Stanton K, Constable IJ (1984) Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables. Diabetologia 27:568–573
Miller NE, LaVille A, Crook D (1985) Direct evidence that reverse cholesterol transport is mediated by high-density lipoprotein in rabbit. Nature 314:109–111
Abbott RD, Carroll RJ (1984) Interpreting multiple logistic regression coefficients in prospective observational studies. Am J Epidemiol 119: 830–836
Zavaroni I, Bonora E, Pagliara M, Dall'Aglio E, Luchetti L, Buonanno G, Bonati PA, Bergonzani M, Gnudi L, Passeri M, Reaven G (1989) Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. New Engl J Med 320:702–706
Peiris A, Meuller RA, Smith GA, Struve MF, Kissebah AH (1986) Splanchnic insulin metabolism in obesity. Influence of body fat distribution. J Clin Invest 78:1648–1657
Wingard DL, Barrett-Connor E, Criqui MH, Suarez L (1983) Clustering of heart disease risk factors in diabetic compared to nondiabetic adults. Am J Epidemiol 117:19–26
Zavaroni I, Dall'Aglio E, Bonora E, Alpi O, Passeri M, Reaven GM (1987) Evidence that multiple risk factors for coronary artery disease exist in persons with abnormal glucose tolerance. Am J Med 83:609–612
Brunzell JD (1984) Obesity and coronary heart disease: a targeted approach. Arteriosclerosis 4:180–182
Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:595–607
Abbott WG, Lillioja S, Young AA, Zawadzki JK, Yki-Jarvinen H, Christin L, Howard B (1987) Relationships between plasma lipoprotein concentrations and insulin action in obese hyperinsulinemic population. Diabetes 36:897–904 455–465
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bergstrom, R.W., Leonetti, D.L., Newell-Morris, L.L. et al. Association of plasma triglyceride and C-peptide with coronary heart disease in Japanese-American men with a high prevalence of glucose intolerance. Diabetologia 33, 489–496 (1990). https://doi.org/10.1007/BF00405111
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00405111